Advanced Filters
noise
Found 1,204 clinical trials
M Medhat AlBerry, MD

Mothers and Babies Qatar (MB-Q): A Postpartum Depression Intervention

Qatar Mothers and Babies is a 4-year collaboration between Northwestern University Feinberg School of Medicine and Sidra Medicine in Doha, Qatar that will generate and evaluate a cultural and contextual adaptation of the Mothers and Babies intervention for pregnant Arabic-speaking women in Qatar. The study will examine the feasibility and …

18 - 50 years of age Female Phase N/A
M Melanie Herschel

Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis

This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.

18 years of age All Phase N/A
S Sujen Maharjan

Sensing Technologies for Maternal Depression Treatment in Low-Resource Settings

In certain low- and middle- income country settings, there is a disproportionate level of untreated postpartum depression that presents both acute and long-term risks to a mother's well-being. Although there is increasing willingness among health systems to involve non-specialists, such as community health workers, in the delivery of psychosocial interventions …

15 - 45 years of age Female Phase N/A
K Kim Bullock, MD

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive virtual reality (VR) headset to engage in behavioral activation (BA) for older adults diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using …

65 years of age All Phase N/A

Vitamin B6 and Depression in Pregnant and Peri-partum Women

Perinatal depression is a highly prevalent and serious health issue during pregnancy. According to statistics, approximately one out of every ten postpartum women experiences this condition. Symptoms can manifest as mood fluctuations or emotional lows. Unfortunately, these symptoms are often overlooked by patients themselves or misinterpreted by others as normal …

20 - 50 years of age Female Phase N/A
D Dorjee Bargeman

Powerly - Science-based Digital Intervention Preventing Postpartum Depression and Anxiety

The goal of this clinical trial is to determine if the Powerly app can help prevent postpartum depression and anxiety in healthy pregnant women. The main questions it aims to answer are: Does the Powerly app reduce postpartum depression and anxiety? Does it improve emotion regulation and maternal bonding with …

18 years of age Female Phase N/A
A Alex Coles, MSc

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to assess the feasibility, tolerability, and preliminary efficacy of psilocybin therapy for adults with chronic neuropathic pain and co-morbid treatment …

18 - 65 years of age All Phase 2
K Karen G Martinez-Gonzalez, MD, MSc

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

This study will explore the effects of esketamine (Spravato®), an FDA-approved nasal spray, on adults diagnosed with treatment-resistant depression (TRD). All participants will receive esketamine as prescribed by a healthcare professional in a clinical setting. The purpose of this research is to understand whether adding therapeutic support in the form …

21 - 65 years of age All Phase 4
L Laina McAusland, MSc

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression

This is a parallel arm randomized (1:1) controlled trial. Adolescents aged 12-17 years (n=452) who are starting or changing a selective serotonin reuptake inhibitor (SSRI) for depression and/or anxiety will be randomly allocated to receive 12-weeks of pharmacogenetic-guided antidepressant therapy (experimental intervention) or current prescribing guidelines/recommendations guided therapy (control intervention).

12 - 17 years of age All Phase N/A
M Metin Çınaroğlu, Phd

EFCT Vs. BCT for Depression and Anxiety in Married Couples

This study compares the effectiveness of Emotion-Focused Couples Therapy (EFCT) and Behavioral Couples Therapy (BCT) in reducing depression and anxiety symptoms in married couples. A total of 150 married couples aged 18-65 will be screened, and 60 couples with high depression and anxiety levels will be selected. These couples will …

18 - 65 years of age All Phase N/A

Simplify language using AI